The aim of this study was to validate and elaborate the previous findings of a differential role for AR on the outcome depending on ER status, using breast cancer-related death as endpoint, in an independent cohort with longer follow-up, the population-based Malmö Diet and Cancer Study (MDCS). The gene discussed is AR; the disease is breast cancer.